These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17191697)

  • 1. [Potential of active specific immunotherapy using allogeneic vaccines in treatment of malignancies].
    Moiseenko VM; Danilova AB; Tiukavina NV
    Vopr Onkol; 2006; 52(3):258-66. PubMed ID: 17191697
    [No Abstract]   [Full Text] [Related]  

  • 2. Mimotope vaccines for cancer immunotherapy.
    Sharav T; Wiesmüller KH; Walden P
    Vaccine; 2007 Apr; 25(16):3032-7. PubMed ID: 17276556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines for cancer too.
    Yu M; Finn OJ
    Cancer Immunol Immunother; 2006 Feb; 55(2):119-30. PubMed ID: 16032397
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancing immune responses for cancer therapy.
    Xue SA; Stauss HJ
    Cell Mol Immunol; 2007 Jun; 4(3):173-84. PubMed ID: 17601371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation of therapeutic cancer vaccines require smart vaccine design.
    Mansour M
    Hum Vaccin; 2010 Dec; 6(12):959-61. PubMed ID: 21487238
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards progress on DNA vaccines for cancer.
    Lowe DB; Shearer MH; Jumper CA; Kennedy RC
    Cell Mol Life Sci; 2007 Sep; 64(18):2391-403. PubMed ID: 17565444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic cancer vaccines.
    Ward S; Dalgleish A
    Vaccine; 2007 Sep; 25 Suppl 2():B1-3. PubMed ID: 17681649
    [No Abstract]   [Full Text] [Related]  

  • 10. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
    Nedospasov SA; Kuprash DV
    Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies.
    Jensen SM; Fox BA
    Cancer Treat Res; 2005; 123():293-336. PubMed ID: 16211876
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
    Urba WJ; Nemunaitis J; Marshall F; Smith DC; Hege KM; Ma J; Nguyen M; Small EJ
    J Urol; 2008 Nov; 180(5):2011-7; discussion 2017-8. PubMed ID: 18801509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines to treat cancer--an old approach whose time has arrived.
    Hellstrom KE; Hellstrom I
    J Cell Biochem; 2007 Oct; 102(2):291-300. PubMed ID: 17729239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer vaccines: a promising cancer therapy against all odds.
    Silk AW; Finn OJ
    Future Oncol; 2007 Jun; 3(3):299-306. PubMed ID: 17547525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile: association for cancer immunotherapy (CIMT).
    Huber C
    Hum Vaccin Immunother; 2012 May; 8(5):546. PubMed ID: 22647579
    [No Abstract]   [Full Text] [Related]  

  • 20. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
    Brockstedt DG; Dubensky TW
    Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.